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ABSTRACT
Background and Objectives: Pyeloplasty, whether open
or laparoscopic, has been the mainstay of treatment for
ureteropelvic junction obstruction (UPJO). A nonstented
pyeloplasty has only been reported in the pediatric liter-
ature. Herein, to the best of our knowledge, we report the
first published experience with laparoscopic stentless py-
eloplasty (LSP) in the adult population.
Methods: Patients with a normal contralateral kidney
who underwent a laparoscopic pyeloplasty were included
in this study. A dismembered pyeloplasty was performed
without the placement of a ureteral stent. Functional Tc-
99m MAG3 renal-scan data were compared with results at
4 weeks and 6 months postoperatively. Perioperative
complications and long-term follow-up were prospec-
tively gathered.
Results: To date, 5 patients have undergone LSP with a
mean follow-up of 15.7 months. Mean age and body mass
index of this group were 42.8 years and 29.3 kg/m
2,
respectively. Mean operative time, estimated blood loss,
and hospital stay were 196 minutes, 58 mL, 1.6 days,
respectively. Three patients had right-sided UPJO, and 2
patients had left UPJO. No patient had undergone previ-
ous surgery for UPJO. All patients had a ureteral stent in
place at the time of surgery. No intraoperative complica-
tions occurred. Only one patient complained of flank pain
on POD1. No obstruction or urinary extravasation was
seen on retrograde pyelography, but a ureteral stent was
placed. During our follow-up, all patients had complete
resolution of their symptoms. Postoperative renal scans
demonstrated improved urinary drainage in all patients.
Conclusion: Our initial experience suggests that in ex-
perienced hands, LSP may be an effective method for
treating UPJO.
Key Words: Stent, Laparoscopic, Pyeloplasty, Ureteropel-
vic junction obstruction.
INTRODUCTION
Over the last century, the surgical management of uret-
eropelvic junction obstruction (UPJO) has dramatically
evolved.1 Various open surgical techniques have been
described based on the cause, location, and length of the
UPJO. The most popular repair is the Anderson-Hynes
dismembered pyeloplasty, which has universal applica-
tion and is accepted as the gold standard of treatment.2–5
With the development of endoscopic techniques and
equipment, minimally invasive approaches have come
into favor in the treatment of patients with primary and
secondary UPJO. A variety of endoscopic treatments via
antegrade and retrograde approaches have been de-
scribed.6–12 More recently, with advancing laparoscopic
skills and the introduction of robotic-assisted surgery,
many centers have moved to laparoscopic pyeloplasty
(LP) as first-line therapy.13–27 Improved suturing skills and
the use of robotic assistance have greatly facilitated lapa-
roscopic dismembered pyeloplasty for primary and sec-
ondary repairs.
The use of ureteral stents following pyeloplasty ensures
adequate drainage, particularly in the presence of postop-
erative edema. For similar reasons, stents are commonly
used after ureteroscopy–although some controversy still
exists regarding its necessity after uncomplicated uretero-
scopic stone removal.28 In the pediatric population, stent-
less pyeloplasty has been found to be safe.5 The advan-
tages of stent placement following pyeloplasty include
lowering the risk of urinoma formation following UPJ
repair5 and providing support and alignment of the fresh
suture line.29 The importance of the stent is highlighted
when the anastamosis is not watertight, or after endopy-
elotomy, allowing healing of the defect while urine is
diverted by the stent. However, ureteral stents are not free
from risk, and potential problems include migration, en-
crustation, retained or forgotten fragments,30 irritative uri-
nary symptoms, exposure of the upper urinary tract to
high pressure during urination, flank pain, and increased
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SCIENTIFIC PAPERrisk of infection.31,32 In a porcine model, Soria et al33
evaluated whether it is possible to reduce the duration of
ureteral stenting following endopyelotomy, and thus re-
duce side-effects. Ureteral stent placement for 1 week was
found to be insufficient to assure correct healing and
evolution of the UPJ following endopyelotomy. Stenting
for 3 weeks was shown to be effective, and it was there-
fore not necessary to extend stenting time to 6 weeks.
In the senior surgeon’s experience (ALS), 17 stented LPs
have been performed to date. Excellent outcomes have
been previously reported with the use of the LapraTy clip
during collecting system reconstruction.17 Although the
role of stents has been well described after endopy-
elotomy, its role after laparoscopic pyeloplasty, where
watertight closure can be achieved, is unclear. We report
our initial experience with laparoscopic stentless pyelo-
plasty (LSP).
METHODS
This is an Institutional Review Board approved, prospec-
tive collection and retrospective analysis of data obtained
from patients specifically undergoing LSP. Between No-
vember 2004 and February 2006, 6 consecutive patients
were treated without the placement of a postoperative
stent, all of whom were operated on by the same surgeon
(ALS). One of these patients underwent a ureterocalicos-
tomy and was excluded from the analysis. All patients had
documented UPJO by Tc-99m MAG3 renal scintigraphy.
In addition, all patients had undergone retrograde ureteral
stenting by their local urologist before being seen at our
center.
All patients underwent a transperitoneal laparoscopic dis-
membered pyeloplasty, as previously described.17 Briefly,
after cystoscopy and ureteral stent removal followed by
repeat retrograde urography, patients were placed in a
lateral decubitous position. After port placement, the co-
lon was reflected medially followed by identification of
the ureter either at the level of the lower pole or near the
level of the renal hilum. The ureter was dissected until the
area of obstruction was identified. The collecting system
was divided just cranial to the narrowest point, and the
ureter was then spatulated 2 cm along its lateral aspect.
The capacious pelvis was minimally spatulated along its
medial aspect and reduced appropriately if excessive tis-
sue was present. The anastomosis was performed using
4–0 absorbable Vicryl suture on an SH-needle beginning
with the posterior layer with a free hand-tied knot and
proceeding with a continuous suture in a lateral-to-medial
direction. The suture line was performed by placing the
needle from outside-to-in on the renal pelvis and inside-
to-out on the ureter side. A Lapra-Ty clip (Ethicon Endo-
Surgery, Inc., Cincinnati, OH) was used to complete the
suture line at the medial aspect of the renal pelvis. The
anterior layer was completed in a similar fashion by using
a second 4–0 Vicryl suture secured with a Lapra-Ty clip.
A transperitoneal drain was placed along with a urinary
catheter in the bladder. Forced diuresis along with intra-
venous indigo-carmine was provided by the anesthesia
team to visually inspect the anastamotic closure.
On the morning of postoperative day (POD) 1, the blad-
der catheter was removed, and the drain was removed 12
hours later before hospital discharge, after the patient had
voided without any increase in drain output. All patients
had a follow-up Tc-99m MAG3 renal scintigraphy at 4
weeks and 6 months following surgery.
Total analgesia was reported in equivalent milligrams of
injectable morphine and was calculated for duration of
in-patient stay only. Data were maintained and analyzed
with File Maker Pro (File Maker Inc, Santa Clara, CA).
RESULTS
Five patients (3 female, 2 male) underwent LSP with a
mean follow-up of 15.7 months (range, 7 to 24). Average
age of the patients was 42.8 years (range, 33 to 64) with an
average body mass index of 29.3 kg/m
2 (range, 19.3 to
54.9). Three patients had right UPJO, 2 had left UPJO.
None had undergone a previous procedure for the repair
of obstruction. However, all patients had indwelling ure-
teral stents placed before the time of surgery. Mean split
renal function for the obstructed kidney by Tc-99m MAG3
scan was 36% (range, 15 to 52) (Table 1). Three patients
were noted to have a crossing vessel, while the other 2
patients had dense, fibromuscular adhesions surrounding
the UPJ. Laparoscopic repair was transposed in all cases
with crossing vessels. Mean operative time and estimated
blood loss were 196 minutes (range, 145 to 284) and 50
mL (range, 10 to 150), respectively. Average time to reg-
ular diet was 13.3 hours (range, 5 to 35). Mean durations
of postoperative urinary catheter and abdominal drain
were 0.9 days (range, 0.5 to 1.5) and 1.6 days (range, 1 to
2.5), respectively. Similarly, mean length of hospital stay
was 1.6 days. One patient was kept in the hospital one
extra day due to difficulty voiding after catheter removal.
Mean analgesia consumption was 42.1 mg (range, 21 to
65) of equivalent morphine.
No intraoperative complications were noted. One periop-
erative complication occurred. This involved patient #5 in
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UPJO. The night of the surgery, the patient complained of
colic-type flank pain with intractable nausea and vomit-
ing. A retrograde pyelogram was performed on the morn-
ing of POD 1, which demonstrated a normal caliber ureter
with mild hydronephrosis. No extravasation of contrast
occurred, and the UPJ anastamosis was patent. Although
there was no obvious evidence of obstruction, a 6F ure-
teral stent was placed without difficulty. Multiplanar fluo-
roscopic views ensured proper placement of the guide-
wire and stent in the collecting system. The patient noted
complete resolution of symptoms, however, did note
moderate irritatitve voiding symptoms requiring anticho-
linergic medications and flank discomfort while voiding
during his recovery period. Four weeks thereafter, the
ureteral stent was removed. No further complications
were observed 7 months postoperatively.
Follow-up split function with MAG-3 renal scans at both 4
weeks and 6 months following LSP were not significantly
different from preoperative values (Table 1). Otherwise,
all patients remained asymptomatic throughout their fol-
low-up period with no evidence of obstruction. One pa-
tient experienced transient right flank-region pain 10
months postoperatively. This discomfort lasted only a few
days and quickly resolved. Abdominal ultrasound at that
time revealed no hydronephrosis, however, did demon-
strate several gallbladder stones. Follow-up scan at that
time noted drainage with T-1/2 of 26 minutes, which had
improved from the patient’s preoperative state of com-
plete obstruction. A more recent renal scan 18 months
postoperatively demonstrated a further improvement in
T1/2 of 16 minutes and a stable split renal function, with
no recurrence of flank discomfort. In addition, this patient,
the only one with preoperative baseline renal insuffi-
ciency, had an improvement in serum creatinine from 2.5
mg/dL to 2.0 mg/dL. To date, all patients have no pain or
symptoms secondary to recurrent UPJO.
DISCUSSION
Ureteral stenting in children typically requires a second
procedure with the patient under anesthesia for stent
removal. The case for nonstented pyeloplasty has been
addressed in a review study of the pediatric literature
where it has been shown to be safe and accepted as a
standard of care.5
In general, the indications for ureteral stenting are many,
and their use has become common in a urologic practice,
especially after a pyeloplasty where a ureteral stent typi-
cally will be placed for 4 weeks to 6 weeks postop.34 The
most recent and largest published series to date, from
Johns Hopkins, documents 4-week routine stenting fol-
lowing laparoscopic pyeloplasty.15 Unfortunately, stent
use is not without potential complication. In one study
evaluating the morbidity of stents, a complication rate of
94% (103/110 patients) was reported, which included in-
fection, flank pain with voiding, stent migration, and stent
fragmentation.31 Similarly, using validated questionnaires,
Joshi et al32 reported that 78% of the 62 respondents noted
bothersome urinary symptoms that encompassed urinary
urgency, frequency, incontinence, and hematuria. In ad-
dition, 80% of respondents experienced stent-related pain
affecting daily activities, as well as some respondents
noting sexual dysfunction (32%) and reduced work capac-
ity (58%).11 In the senior surgeon’s prior experience with
17 stented laparoscopic pyeloplasties, 13 patients (77%)
complained of irritative voiding symptoms. Nine (53%) of
these individuals required anticholinergic medication to
Table 1.
Summary of Preoperative and Postoperative Tc-99m MAG3 Renal Scans
Pt # UPJO*
Side
Age/Sex Preoperative 4 Week Postoperative 6 Month Postoperative
OR
Finding
MAG3
Split
Function
T 1/2
(min)
Symptoms MAG3
Split
Function
T 1/2
(min)
Symptoms MAG3
Split
Function
T 1/2
(min)
1 R 38/F CV 52 14 None 51 6 None 49 5
2 R 64/F DA 36 60 None 36 26 None 40 16
3 R 33/M CV 45 60 None 50 11 None 48 9
4 L 37/F DA 15 43 None 17 24 None 19 20
5 L 42/M CV 32 37 None 40 13 None 40 14
*UPJO  ureteropelvic junction obstruction; CV  crossing vessel; DA  dense adhesion.
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removal 3 weeks postoperatively (unpublished data).
In our initial LSP experience, we found no increased
morbidity from performing this technique. The risks of
stent migration, encrustation, stent syndrome (defined as
dysuria, frequency, flank pain, and hematuria commonly
seen with short-term placement), increased risk of infec-
tion, and stent encrustation were replaced by the risk of
possible postop obstruction and/or urinoma formation
that would require retrograde stent placement. Such a
maneuver is potentially dangerous in that wire placement
may injure the anastamosis or be mistakenly placed out-
side the collecting system. Proper endoscopic equipment
(eg, hydrophilic coated guidewire) and skill are required
to ensure safe placement. In our study, only one patient
experienced symptoms suggestive of postoperative ob-
struction. Retrograde pyelography, however, failed to
demonstrate obstruction. Nevertheless, a ureteral stent
was placed for 4 weeks, during which time, the patient
complained of irritative voiding symptoms and renal pain
during voiding. Furthermore, the oldest patient in this
cohort (patient #2) with a BMI of 54.9 kg/m
2 who had
recurrent bouts of pyelonephritis and flank pain at the
time of presentation had dense peri-ureteral adhesions
noted at the time of surgery. This patient with a preoper-
ative split function of 35% on the right side, and complete
UPJO was noted to have a partial obstruction on fol-
low-up renal scan. At 10-months postoperatively, the pa-
tient experienced a 1-week bout of transient flank pain for
several months. Ultrasonography and a repeat renal scan
study excluded recurrent UPJO. The concept of cholecys-
titis was considered by the presence of gallbladder stones
and sludge coupled with moderate gallbladder wall thick-
ening. This patient has otherwise remained asymptomatic
with improved serum creatinine and no recurrent bouts of
pyelonephritis despite moderate objective improvement.
We did not experience any anastomotic leaks based on
abdominal drain outputs. No infectious or obstructive
complications related to the use of Lapra-Ty clips were
encountered.35 Although postoperative CT-abdominal
scans were not routinely obtained, none of the patients
exhibited signs or symptoms consistent with urinoma for-
mation, which compares favorably with a previous report
that noted a 5% prolonged urinary leak and 5% rate of
urinoma formation in a nonstented pediatric cohort.5
The benefits of a stentless procedure, if proven as effica-
cious and safe as a stented pyeloplasty, include reducing
the risk for infection, eliminating the risk of developing
stent syndrome and the need for follow-up cystoscopy 4
weeks to 6 weeks postoperatively for stent removal. This
may ultimately prove to be less traumatic for the patient.
The technical advantage of using the LSP technique is the
avoidance of stent interference during suture-related re-
construction. LSP allows for optimal visualization and di-
rect access to the spatulated edges for anastamosis, elim-
inating the risk of entangling the suture around the stent
and stent migration. As such, these factors help optimize
the likelihood of a watertight anastamosis. Comparative
results were noted to our previously published stented
laparoscopic pyeloplasty series.17 Comparing our opera-
tive times to times of previously published series shows
that our mean time of 196 minutes is comparable to that of
other contemporary large series, which range between
123 minutes and 252 minutes.13–27 When assessing hospi-
talization, we noted a shorter mean stay of approximately
1.6 days versus that of other series, which are reported to
be between 2.6 days to 4.5 days.13–16
Overall, there was 100% subjective success in our 5 pa-
tients with a mean follow-up of 15.7 months. With regards
to objective success, all patients demonstrated stabilized
or improved split renal function on MAG-3 renal scan and
improved drainage T-1/2 times.
We are cautiously optimistic about these results. Several
limitations of this study warrant discussion. The small
patient number and short follow-up limit the power to
perform statistical analysis. Although some critics may
argue that extended follow-up beyond 24 months would
be optimal, Inagaki et al15 from Johns Hopkins evaluated
147 LPs with a mean follow-up of 24 months and demon-
strated that most failures occur within 6 months. Due to
small numbers in a retrospective review, we were not able
to assess the benefit of LSP for primary versus secondary
UPJO. A prospective, randomized study comparing
stented with nonstented methods is needed to address the
dogma of ureteral stent placement and evaluate the post-
operative complication parameters. As such, it will take a
significantly larger cohort of patients with a longer fol-
low-up to assess whether adult LSP is comparable to
published success rates of stented laparoscopic pyelo-
plasty of 81 to 99.13–16 Currently, the standard of care
remains to place a stent after ureteral repair. We still
advocate the use of a stent in all patients with a solitary
kidney, patients with a difficult ureteral anastomosis, sig-
nificant bleeding during UPJO repair, and those individu-
als with a thick, noncompliant ureter due to chronic in-
flammation.
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Utilizing a stentless technique has proved to be efficacious
in a small cohort of patients with limited follow-up. Our
minimal incidence of postoperative complications is likely
related to meticulous surgical technique and ability to
minimize laxity on our suture line with the aid of addi-
tional Lapra-Ty clips as needed. Certainly, a larger cohort
with longer follow-up will be required to prove the dura-
bility and safety of a stentless laparoscopic pyeloplasty,
which may ultimately revolutionize previous dogmatic
assertions.
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